GlobeNewsWire
28 Oct 2026, 02:03 UTC · 2h ago
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Impact · against what's priced in
The reminder for investors to join the class action lawsuit is not a catalyst. The market has already adjusted for the 14% stock decline and the ongoing legal friction regarding privacy and billing practices.
- HIMS+0.00
Already priced in
- The price assumes
Significant legal and regulatory friction, including FTC lawsuits over data privacy and billing practices.





